Caesarstone Ltd.
CSTEBusiness Summary
Caesarstone Ltd. is a global multi-material designer, producer, and reseller of surfaces, primarily used as countertops in residential and commercial buildings 1. The global countertop industry generated approximately $151.6 billion in sales to end consumers in 2024, based on average installed price, which includes fabrication, installation, and other service-related costs 2. The company's products are sold in approximately 60 countries through a combination of direct sales and a network of independent distributors 3. Engineered stone countertops are a growing category, with global engineered quartz sales to end-consumers growing at a compound annual growth rate of 14.3% between 1999 and 2024, compared to a 5.2% compound annual growth rate in total global countertop sales 4. Porcelain sales to end-consumers grew at a compound annual growth rate of 30.5% between 2016 and 2024 5.
The company faces intense competitive pressures from other surface materials and brands, competing on factors such as pricing, brand awareness, product quality, differentiation, design, breadth of offerings, and technological innovation 6. Competitors may produce or source similar products at lower costs, potentially reducing Caesarstone's market share and limiting its ability to increase prices 7. The engineered stone and porcelain surface market is highly fragmented, with growing competition from low-cost manufacturers from Asia and Europe, and large multinational companies investing in their production capabilities 8.
Caesarstone generates revenue from sales of surfaces, and to a lesser extent, their fabrication and installation services, and ancillaries 9. The majority of sales are to fabricators and resellers in direct markets and to third-party distributors in indirect markets 10. Direct sales accounted for 89% of revenues for the year ended December 31, 2025 11. The company's business model includes providing fabrication and installation services in certain market channels in the U.S., Canada, Israel, and Australia, which are sourced from third-party fabricators 12.
The company's products are generally marketed under the Caesarstone brand and Lioli brand, with products sold through IKEA marketed as LOCKEBO and KASKER 13. Engineered stone products are comprised of an average of 85% minerals blended with polyester and pigments 14. Porcelain products are comprised of clay minerals, natural minerals, and additives 15. The product offerings include collections such as Classico, Supernatural, Metropolitan, Outdoor, and Porcelain 16. In 2024, Caesarstone began transitioning its portfolio to crystalline silica-free surfaces (CSF), which may contain traces of crystalline silica of up to 1%, made from approximately 80% recycled materials 17. Additionally, following the Omicron acquisition, the company offers resale of natural stone, sinks, and various ancillary fabrication tools and materials in the United States 18.
In 2025, products produced by third parties accounted for approximately 51% of revenues 19. The company's engineered stone products are now manufactured by third-party Production Business Partners (PBPs) located in the Far East, India, the Middle East, and Europe, following the closure of its own engineered stone production facilities 20. Porcelain products are manufactured at the in-house facility in Morbi, Gujarat, India, and by third-party PBP partners 21. In 2025, approximately 73% of total engineered stone sourcing was manufactured by PBPs, with this trend expected to significantly increase in 2026 to include all engineered stone products 22. Approximately 49% of PBP-manufactured products (or 36% of total engineered stone products) were sourced from "Supplier A," and approximately 31% (or 23% of total engineered stone products) from "Supplier B" 23.
For the fiscal year ended December 31, 2025, Caesarstone reported total revenue of $397.2 million 24. Gross profit was $73.280 million 25, resulting in a gross margin of 18.4% 26. Operating loss for the period was $125.709 million 27, representing an operating margin of -31.6% 28. Net loss was $137.759 million 29, and net loss attributable to controlling interest was $137.467 million 30, with a margin of -34.6% 31. Diluted EPS is not explicitly provided in the summary financial data. Adjusted EBITDA was a loss of $32.560 million 32, with an adjusted EBITDA margin of -8.2% 33. Adjusted net loss attributable to controlling interest was $51.925 million 34, with a margin of -13.1% 35. Capital expenditures for 2025 amounted to $9.0 million 36. As of December 31, 2025, the company had outstanding bank credit of $2.4 million 37, all payable within 12 months 38. Cash and cash equivalents are not explicitly stated in the summary.
Revenue decreased by $46.0 million, or 10.4%, to $397.2 million in 2025 from $443.2 million in 2024 39. On a constant currency basis, 2025 revenue was lower by 10.5% year-over-year 40. Gross margin decreased to 18.4% in 2025 from 21.8% in 2024 41. The adjusted gross margin decreased from 22.1% in 2024 to 19.0% in 2025 42. The adjusted EBITDA margin decreased from a negative 2.6% in 2024 to a negative 8.2% in 2025 43. The margin of adjusted net loss attributable to controlling interest increased from an adjusted net loss of 6.7% in 2024 to an adjusted net loss of 13.1% in 2025 44. Research and development expenses increased by $0.7 million or 14.6%, reaching $5.7 million in 2025, compared to $4.9 million in 2024 45. Selling and marketing expenses decreased by $6.7 million, or 7.8%, to $79.5 million in 2025, compared to $86.2 million in 2024 46. General and administrative expenses increased by $0.4 million, or 0.9%, to $39.5 million in 2025 from $39.1 million in 2024 47. Legal settlements and loss contingencies, net, increased by $18.4 million, from $7.2 million expenses in 2024 to $25.6 million in 2025 48.
During 2025, the company completed the acquisition of the remaining minority equity interests in Lioli Ceramica Pvt. Ltd. for approximately $1.9 million, resulting in 100% ownership of Lioli as of December 31, 2025 49. The manufacturing network underwent restructuring, shifting focus from in-house production, with operations discontinued at Sdot-Yam, Israel, Bar-Lev, Israel, and Richmond Hill, GA, USA facilities 50. Impairment charges of approximately $45.7 million were recorded in 2025, primarily related to the Bar Lev facility, the held-for-sale Richmond Hill facility, and the right-of-use asset at the Bar Lev facility 51. Restructuring expenses related to manufacturing facility closures and partial asset sales totaled approximately $3.1 million in 2025 52.
Business Outlook
A key element of Caesarstone's strategy is to expand sales in certain existing markets, such as the United States, and additional new markets and offerings with high growth potential 53. The company is optimizing its distribution network in the United States, including through the expansion of its brand into the South, Southeast, and Ohio Valley markets via the Omicron Acquisition 54. A growing portion of revenues is attributable to installation and fabrication services 55. The company estimates it can continue to expand its brand and product sales in the United States, where engineered surfaces represented 4.9% of total countertops by volume installed in 2024 56.
The company's R&D efforts are focused on the development of innovative CSF products, currently primarily tailored for the Australian market 57. Additionally, the R&D department has expanded its focus to include the development of porcelain products for various global markets and diverse applications, working in close collaboration with the manufacturing facility in Lioli, India 58. The company aims to increase purchases from PBPs in 2026 59.
Caesarstone attributes the decrease in adjusted EBITDA margin in 2025 mainly to lower sales, including lower average selling prices, increased manufacturing costs per unit due to lower capacity utilization in the Bar Lev plant, resulting in lower fixed-costs absorption, higher logistics costs, and increased tariffs to the U.S. market 60. These impacts were partially offset by savings from an increased portion of PBP-produced product sales and operating expenses savings 61. The company is implementing a digital transformation to better streamline processes and support its business strategy, with technological and digital investments geared towards operational enhancements in supply chain management and production, along with improvement of go-to-market tools 62.
The company's primary capital requirements have been to fund production capacity expansions, investments in and acquisitions of third-party distributors, and the establishment of German operations 63. Other capital requirements include funding working capital needs, legal proceedings, operating costs, debt payments, share repurchases, and dividends 64. Capital expenditures for 2025 were $9.0 million 65. The company's inventory strategy is to maintain sufficient inventory levels to meet anticipated customer demand, with inventory significantly impacted by sales in the United States, Australia, and Canada due to the 20-100 days required to ship products from PBP sources 66. The company believes that, based on its current business plan, its cash, cash equivalents, short-term bank deposits, and cash from operations will be sufficient to meet capital expenditure, working capital, and liquidity needs for at least the next twelve months 67.
The company's capital needs could increase materially, and liquidity and cash flows could be materially affected by the uncertainty related to bodily injury claims 68. The company is subject to multiple lawsuits alleging injuries associated with exposure to respirable crystalline silica dust 69. As of December 31, 2025, a provision of $47.2 million was recorded for probable and estimable exposure with respect to pending claims 70. If there is an unfavorable outcome, subject to insurance availability, the payment of damages could be significant and materially and adversely impact cash flows 71. The company has lease payment obligations of $133.3 million as of December 31, 2025, with $29.9 million payable within 12 months 72. Purchase obligations for products and raw materials amounted to $15.9 million as of December 31, 2025, all payable within 12 months 73. The company had outstanding bank credit of $2.4 million as of December 31, 2025, all payable within 12 months, with future interest payments totaling $0.2 million, also payable within 12 months 74.
Risk Factors
Caesarstone faces several material risks, including adverse outcomes and potential losses from bodily injury claims related to respirable crystalline silica exposure, with 618 injured persons globally as of December 31, 2025 75, and a provision of $47.3 million recorded for probable and estimable exposure 76. The company is unable to obtain insurance coverage for future silicosis claims, and existing coverage is disputed by insurers, potentially leading to insufficient coverage 77. Global trade is affected by governmental involvement, including antidumping and countervailing duties, which can cause unforeseeable market changes and increase costs, such as the 3.18% subsidy rate assigned to porcelain products imported from India 78. Changes in laws and regulations relating to hazards associated with engineered stone surfaces, such as the ban on engineered stone slabs containing crystalline silica in most Australian states and territories effective July 1, 2024 79, may adversely affect the business. Economic downturns, particularly in home renovation and construction, high inflation, and increased interest rates, may lower demand for products 80. The company relies on a network of third-party Production Business Partners (PBPs), with approximately 24% of products manufactured at more than one PBP facility 81, and disruptions or failures in managing these relationships could adversely affect competitive position, results, or profitability. Fluctuations in currency exchange rates, particularly the Australian dollar, Canadian dollar, NIS, and Euro against the U.S. dollar, may materially and adversely affect profitability 82. The inability to offset or pass on increases in costs or adverse changes in global sourcing, manufacturing, and supply conditions could materially adversely affect financial results 83. The company may need to raise funds to finance capital needs, which could dilute shares, increase financial expenses, or limit business activities 84. Disruptions to or failure to upgrade IT systems globally may impair operations and hinder growth 85. The steps taken to protect brand, technology, and intellectual property may be inadequate, and the company may not succeed in preventing others from appropriating its intellectual property 86. Compliance with continuously evolving privacy and data protection laws and regulations, such as the California Consumer Privacy Act (CCPA) and the General Data Protection Regulation (GDPR), may result in significant liability 87. The company may have exposure to greater-than-anticipated tax liabilities, including challenges to transfer pricing arrangements and the allocation of income related to production outside of Israel 88. Environmental, health, and safety regulations, such as those in India, may be costly or difficult to comply with, potentially leading to civil and criminal sanctions 89. Litigation, disputes, or other proceedings, including a putative class action lawsuit seeking medical monitoring for workers exposed to artificial stone dust in California 90, could result in unexpected expenses. Failure to meet ESG expectations or standards could adversely affect the business 91. Operating results may suffer due to failure to manage international operations effectively or regulatory changes in foreign jurisdictions 92. Conditions in Israel and regional instability may adversely affect operations, including the call-up of employees for military reserve duty 93. The tax benefits available to the Israeli facilities, such as the "Preferred Enterprise" status, require meeting various conditions and may be terminated or reduced in the future 94. The substantial share ownership position of Kibbutz Sdot-Yam and Tene, which together beneficially owned 40.6% of outstanding shares as of February 27, 2026 95, limits the ability of other shareholders to influence corporate matters.
Management Priorities
Management's message to shareholders emphasizes the company's mission to be the leading choice for surfaces globally, with a significant portion of future growth expected from the U.S. market, which is seen as having the greatest growth opportunity 96. The company believes that long-term competitiveness requires both organic growth and strategic acquisitions 97. Management has successfully executed on this strategy in recent years, including the 2020 acquisitions of Lioli and Omicron, and the 2022 acquisition of Caesarstone Scandinavia 98. The company is actively working to optimize its global production footprint by shifting from in-house production to sourcing engineered stone products from third-party Production Business Partners (PBPs) 99. In 2025, the company completed the acquisition of the remaining minority interests in Lioli for approximately $1.9 million, achieving 100% ownership 100. Management is also focused on developing innovative crystalline silica-free (CSF) products, particularly for the Australian market, and expanding its porcelain product offerings globally 101. The company is implementing a digital transformation to streamline processes, enhance supply chain management, and improve go-to-market tools 102. Despite a revenue decrease of 10.4% in 2025 to $397.2 million 103, management is implementing cost-saving measures as part of its strategic restructuring plan, which contributed to a decrease in selling and marketing expenses by 7.8% 104.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 4.B, Business Overview
- [2] Item 4.B, Business Overview
- [3] Item 4.A, History and Development of the Company
- [4] Item 4.B, Business Overview
- [5] Item 4.B, Business Overview
- [6] Item 4.B, Competition
- [7] Item 3.D, Risk Factors — We face intense competitive pressures which could materially and adversely affect our results of operations and financial condition
- [8] Item 4.B, Competition
- [9] Item 5.A, Operating Results — Components of statements of income
- [10] Item 5.A, Operating Results — Components of statements of income
- [11] Item 5.A, Operating Results — Components of statements of income
- [12] Item 4.B, Distribution
- [13] Item 4.B, Our Products
- [14] Item 4.B, Our Products
- [15] Item 4.B, Our Products
- [16] Item 4.B, Our Products
- [17] Item 4.B, Our Products
- [18] Item 4.B, Our Products
- [19] Item 4.B, Manufacturing and Facilities
- [20] Item 4.B, Manufacturing and Facilities
- [21] Item 4.B, Manufacturing and Facilities
- [22] Item 4.B, Production Business Partners Relationships
- [23] Item 4.B, Production Business Partners Relationships
- [24] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [25] Item 4.B, Non-GAAP Financial Measures
- [26] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [27] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [28] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [29] Item 4.B, Non-GAAP Financial Measures
- [30] Item 4.B, Non-GAAP Financial Measures
- [31] Item 5.A, Operating Results — Company overview
- [32] Item 4.B, Non-GAAP Financial Measures
- [33] Item 5.A, Operating Results — Company overview
- [34] Item 4.B, Non-GAAP Financial Measures
- [35] Item 5.A, Operating Results — Company overview
- [36] Item 4.A, Principal Capital Expenditures
- [37] Item 5.B, Liquidity and Capital Resources — Debt
- [38] Item 5.B, Liquidity and Capital Resources — Debt
- [39] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [40] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [41] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [42] Item 5.A, Operating Results — Company overview
- [43] Item 5.A, Operating Results — Company overview
- [44] Item 5.A, Operating Results — Company overview
- [45] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [46] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [47] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [48] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [49] Item 5.A, Operating Results — Acquisitions
- [50] Item 4.A, History and Development of the Company
- [51] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [52] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [53] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
- [54] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
- [55] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
- [56] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
- [57] Item 4.B, Research and Development
- [58] Item 4.B, Research and Development
- [59] Item 4.B, Manufacturing and Facilities
- [60] Item 5.A, Operating Results — Company overview
- [61] Item 5.A, Operating Results — Company overview
- [62] Item 4.B, Information Technology Systems
- [63] Item 5.B, Liquidity and Capital Resources
- [64] Item 5.B, Liquidity and Capital Resources
- [65] Item 5.B, Liquidity and Capital Resources — Capital expenditures
- [66] Item 5.B, Liquidity and Capital Resources
- [67] Item 5.B, Liquidity and Capital Resources
- [68] Item 5.B, Liquidity and Capital Resources
- [69] Item 5.B, Liquidity and Capital Resources
- [70] Item 5.B, Liquidity and Capital Resources
- [71] Item 5.B, Liquidity and Capital Resources
- [72] Item 5.B, Liquidity and Capital Resources — Leases
- [73] Item 5.B, Liquidity and Capital Resources — Purchase Obligations
- [74] Item 5.B, Liquidity and Capital Resources — Debt
- [75] Item 3.D, Risk Factors — Adverse outcomes and potential losses from bodily injury claims may have a material adverse effect on our business, operating results, financial condition and cash flows
- [76] Item 8.A, Legal Proceedings — Our Probable Risks Related to Outstanding Claims
- [77] Item 3.D, Risk Factors — We are unable to obtain insurance coverage for future claims relating to silicosis, our entitlement to receive coverage based on existing policies is being disputed by insurers, and our coverage will be insufficient if our position is not accepted by courts and juries
- [78] Item 3.D, Risk Factors — Global trade is affected by governmental involvement, including through antidumping and countervailing duties and these may cause unforeseeable market changes that could adversely impact our financial results
- [79] Item 3.D, Risk Factors — Changes in laws and regulations relating to hazards associated with engineered stone surfaces or with the crystalline silica in stone surfaces may adversely and materially affect our business
- [80] Item 3.D, Risk Factors — Economic downturns, particularly in home renovation and construction may materially and adversely impact end-consumers and lower demand for our products, which may cause our revenues and net income to decrease
- [81] Item 3.D, Risk Factors — Our reliance on our network of third-party Production Business Partners (PBP), including concentration risks relating to certain products, technologies or geographic regions, could materially adversely affect our competitive position, results of operations or profitability
- [82] Item 3.D, Risk Factors — Our results of operations may be materially and adversely affected by fluctuations in currency exchange rates, and we may not have adequately hedged against them
- [83] Item 3.D, Risk Factors — If we are unable to offset or pass on increases in costs or adverse changes in global sourcing, manufacturing and supply conditions, our business, financial condition and results of operations could be materially adversely affected
- [84] Item 3.D, Risk Factors — We may need to raise funds to finance our current and future capital needs, which may dilute the value of our outstanding ordinary shares, increase our financial expenses or limit our business activities
- [85] Item 3.D, Risk Factors — Disruptions to or our failure to upgrade and adjust our information technology systems globally may materially impair our operations, hinder our growth, and materially and adversely affect our business and results of operations
- [86] Item 3.D, Risk Factors — The steps that we have taken to protect our brand, technology and other intellectual property may not be adequate, and we may not succeed in preventing others from appropriating our intellectual property
- [87] Item 3.D, Risk Factors — Compliance with continuously evolving privacy and data protection laws and regulations, and any actual or perceived failure to comply with such laws and regulations may result in significant liability, negative publicity, and/or erosion of trust and could have an adverse effect on our revenues, results of operations and financial condition
- [88] Item 3.D, Risk Factors — We may have exposure to greater-than-anticipated tax liabilities
- [89] Item 3.D, Risk Factors — Environmental, health and safety regulations, industry standards and other similar matters may be costly, difficult or impossible to comply with under our existing operations and could negatively impact our financial condition and results of operations
- [90] Item 8.A, Legal Proceedings — United States
- [91] Item 3.D, Risk Factors — Failure to meet ESG expectations or standards or a failure to effectively pursue our ESG goals could adversely affect our business, results of operations, financial condition, or stock price
- [92] Item 3.D, Risk Factors — Our operating results may suffer due to our failure to manage our international operations effectively or due to regulatory changes in the jurisdictions where we operate
- [93] Item 3.D, Risk Factors — Conditions in Israel and regional instability may adversely affect our operations
- [94] Item 3.D, Risk Factors — The tax benefits that are available to us require us to continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes
- [95] Item 7.A, Major Shareholders
- [96] Item 5.A, Operating Results — Company overview
- [97] Item 5.A, Operating Results — Company overview
- [98] Item 5.A, Operating Results — Company overview
- [99] Item 5.A, Operating Results — Cost of revenues and gross profit margin
- [100] Item 5.A, Operating Results — Acquisitions
- [101] Item 4.B, Research and Development
- [102] Item 4.B, Information Technology Systems
- [103] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
- [104] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
Analysis on 5/22/2026